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Aversions caused by sub-lethal doses of sodium monofluoroacetate (1080) apparently persist 
in captive possums for at least 3 months, during which time such possums remain averse 
(or 'shy') to bait containing either a chronic or acute toxin (Morgan, Meikle & Hickling 
1995). This suggests that when shyness has been induced with cereal 1080, such possums 
cannot be successfully controlled by reapplying cereal bait, regardless of the toxin used. 
However, when a chronic toxin is used in the field it seems that possums eat progressively 
more bait at each night's exposure, until eventually the cumulative dose becomes lethal (R. 
Henderson, unpublished data). 
These pen and field trials suggest different approaches for how best to combat 1080 shyness. 
Further trials were therefore required to clarify this issue, by ascertaining how the type of 
toxin influences the amount of bait that shy possums eat when they next re-encounter cereal 
bait, and whether nightly per capita consumption increases or decreases during prolonged re-
exposure to such baits. 
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BACKGROUND 
A preliminary FRST-funded alternative toxin trial was started at the Landcare Research (NZ) 
LTD. Rangiora pen facility in the 1995/96 financial year. 
The overall goal of this trial was to expose 60 possums, sub-lethally dosed with 1080, to three 
alternative toxins (cholecalciferol, gliftor and brodifacoum). Unfortunately there was high 
possum mortality during acclimatisation and only 30 1080 shy possums were available to be 
trialed. 
The results of this preliminary research (Table 1) suggest 1080 shy possums could be killed 
using a chronic toxin in a new bait matrix. However, the results highlighted two areas of 
uncertainty (summarised in Table 2). The main cause of which was confounding of 
differences in toxin and bait matrix in the 1995/96 trial. For example, the brodifacoum and 
cholecalciferol were presented in commercially produced cereal baits that differed from the 
RS5 bait used in the 1080 sub-lethal dose. 
Table 1: Numbers of 1080 shy possums killed by alternative toxins in cereal baits 
(J. Ross, unpublished data). 
Toxin 
Non-toxic 
1080 
Gliftor 
Cholecalciferol 
Talon 
Toxic loading No. of possums Mean group weight 
(%) (kg) 
8 2.40 + 0.15 
0.08 6 2.44 + 5.3 
0.4 6 2.75+0.17 
0.8 6 2.42 + 0.15 
0.002 5 2.43+0.17 
Mortality 
(%) 
o 
67 
50 
83 
60 
Table 2: Current gaps in knowledge regarding the use of acute and chronic toxins on 
1080 shy possums. 
Acute toxin in RS5 
Chronic toxin in RS5 
Chronic toxin in new matrix 
2 
Unsuccessful 
Unknown 
Successful 
Subsequent discussions within the research team concluded that a study design was required 
that controlled for the familiarity/novelty of both the toxin and the bait matrix. Accordingly, 
a new trial was undertaken that incorporated the new treatment groups stemming from the 
uncertainties highlighted in Table 2. 
OBJECTIVE 
• To determine the role of chronic and acute toxins in combating 1080 shy behaviours in 
possums, with a view to recommending alternative bait formulations that 1080 shy 
possums will accept. 
METHODS 
Animal husbandry 
The trial was undertaken from Aug-Nov 1996 using 96 wild-caught possums housed in 
indoor cages at Landcare Research's captive animal facility at Lincoln. All possums were 
acclimatised to captivity for 6 weeks before the start of the trial. 
The trial aimed to mimic non-prefed aerial application of possum control baits (i.e., the first 
bait that each possum encountered was a toxic 1080 cereal pellet; Morgan 1986). Therefore, 
possums were prefed on a range of fruit and vegetables, provided ad libidum. No cereal-based 
food was provided during the acclimatisation period. 
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Health of individual possums was monitored by checking body weight during the 
acclimatisation period. All possums were weighed three times at seven day intervals 
immediately prior to the sub-lethal dose. Significant weight loss over this period (> O.Skg) 
was considered indicative of a stressed possum that should be withdrawn from the trial. 
Typically weight loss was negligible (mean weight loss 0.23 kg) and only 3 of 96 possums 
were withdrawn for this reason. 
During the acclimatisation phase the captive possums were inadvertedly exposed to an 
unidentified viral disease that killed 23 (24%) of the possums. All surviving possums were 
monitored as above to ensure that only healthy possums were used in the bait consumption 
trial. As a further safeguard all possums dying during the bait consumption phase were 
postmortemed to confirm cause of death. An additional six possums were withdrawn from the 
trial because no signs of poisoning were evident at postmortem. 
Induction of bait shyness 
After acclimatisation each possum was weighed and fed 19 of 0.08% 1080 bait per kg 
liveweight (RSS pellet containing 0.1 % cinnamon and green Lavanyl dye). RSS is a 
proprietary mix of cereals and sugar sweeteners supplied by Animal Control Products (ACP) 
Waimate. Normal diet was available on the day of dosing. 
Bait consumption trial 
After one week, shyness was confirmed by presenting each possum with 19 of 0.08% 1080 
bait. If the possum consumed the entire bait it was presented with a further two baits over the 
next two days. If the possum continued to eat the toxic bait on the third exposure it was 
removed from the trial. Possums taking more than one exposure to develop shyness were 
allocated equally amongst the subsequent treatment groups. 
Once the possums were confirmed as shy they remained on the vegetable diet for a further 
week. They were then fe-weighed and divided into six equal-weight treatment groups 
(Table 3). 
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Table 3: Treatment groups for 1996/97 trial conducted at Landcare Captive Animal Facility. 
Group Toxin Conc. l Bait Base Lure Dye No. of 
Familiarity Material possums 
1080 0.08% Familiar RS5 Cinnamon Yes 10 
2 1080 0.08% Unfamiliar Apple-Paste Jaffa No 10 
3 Cholecalciferol 0.6% Familiar Cereal3 Cinnamon Yes 112 
4 Cholecalciferol 0.6% Unfamiliar Apple-Paste Jaffa No 9 
5 Brodifacoum 0.002% Familiar RS5 Cinnamon Yes 11 
6 Brodifacoum 0.002% Unfamiliar Apple-Paste Jaffa No 9 
I Con tinned by laboratory assay. 
2 Including tive possums that received this treatment in the 1995/96 trial. 
3 A commercial bait similar to RS5, manufactured by ICI New Zealand Ltd, Lower Hutt. 
To check for any difference in bait palatability between the three bait matrixes, standard 
Landcare palatability trials (D. Morgan, pers. comm.) were run comparing non-toxic RS5 
pellets (0.1 % cinnamon) with non-toxic apple paste lured with five different concentrations of 
jaffa. Palatability scores were similar (0.51 %) when the jaffa concentration was 0.4% (a 
concentration considered sufficient to mask all three toxins). 
Possums in treatment groups 1-4 were presented with 50g of fresh bait per day. Treatment 
groups 5-6 were presented with 100g of fresh bait daily. All baits were presented in standard 
Landcare metal feed trays. Six control trays were put out each day in adjacent unoccupied 
cages to assess bait weight loss due to desiccation. 
Possum survival and bait consumption for treatment groups 1-4 were monitored daily during 
the two week treatment period. Brodifacoum is a slow-acting toxin, so treatment groups 5-6 
were monitored for bait consumption over four weeks and for survival over eight weeks. 
RESULTS 
Mortality 
All ten 1080 shy possums failed to consume a lethal dose when re-exposed to 1080 in a 
familiar cereal bait matrix. In contrast, the cholecalciferol and brodifacoum toxins III a 
familiar matrix were equally successful, both killing eight out of eleven (73%) of shy 
possums (Table 4). The difference in kill between these toxins and 1080 was statistically 
significant (Fisher Exact test; p = 0.001). 
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Table 4: Numbers of 1080 shy possums killed by alternative toxins in a familiar and 
unfamiliar bait bases. 
Group Toxin Base Material No. of Mean group Numbers 
dying 
Mortality 
(%) 
2 
3 
4 
5 
6 
1080 
1080 
Cholecalciferol 
Cholecalciferol 
Brodifacoum 
Brodifacoum 
RS5 
Apple-paste 
Commercial 
Apple-paste 
RS5 
Apple-paste 
possums weight (kg) 
10 2.72 
10 2.20 
11 
9 
11 
9 
2.71 
2.12 
2.71 
2.35 
o 
4 
8 
9 
8 
9 
0% 
40% 
73% 
100% 
73% 
100% 
1080 toxin in the unfamiliar apple-paste bait killed four out of 10 (40%) possums previously 
made shy with 1080 in a cereal bait (Table 4). Brodifacoum and cholecalciferol had a similar, 
higher, success rate killing nine out of nine (100%) of the 1080 shy possums. 
Bait consumption 
Shy possums exhibited a high level of shyness when re-exposed to 1080 cereal bait. The 
mean amount of bait eaten on the first night was negligible (0.63g) with the subsequent 
nightly consumption reducing further (Table 5 and Appendix 1). 1080 shy possums also 
exhibited a high level of shyness to the cholecalciferol cereal bait. Mean nightly consumption 
then declined, although to a level higher than for the 1080 group. The mean consumption of 
brodifacoum in cereal on the first night (6.62g) was considerably higher than for 1080 and 
cholecalciferol and mean nightly consumption then increased over the next 27 nights. 
Mean total consumption of the 1080 cereal bait was only 2.8g over 14 nights (Table 5 and 
Appendix 1). Consumption of cholecalciferol in cereal bait was low at first however, the 
possums continued to eat small amounts with a mean total consumption of 17.8g over the 14 
nights. Possums eating cholecalciferol took 7-15 days to consume a lethal dose and die. 
Consumption of brodifacoum cereal bait increased after the first night, with a mean total 
consumption of 281 g over the 28 nights. Five out of eight possums eating brodifacoum took 
18-25 days to consume a lethal dose and die. The other three took more than 28 days. As with 
1080 cereal bait, the bulk of the 1080 paste consumption occurred on the first night. 
However, the mean of 1080 paste consumed on the first night (10.48g) was higher than for 
any of the cereal baits. Mean nightly consumption then reduced for the next 13 nights (Table 
5 and Appendix 2). The 1080 shy possums exhibited a low level of shyness to the 
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cholecalciferol paste, consummg a mean of 26.22g on the first night. Mean nightly 
consumption then reduced markedly over the next 13 nights. The 1080 shy possums also 
showed little aversion to the brodifacoum paste, with consumption remaining fairly high 
throughout the trial. 
The total mean consumption of 1080 paste was higher than expected at 43g. Possums 
consuming a lethal dose of 1080 died within 24 hours. The total mean cholecalciferol paste 
consumption was 42g with the bulk of this consumed on the first night. Possums eating 
cholecalciferol paste took 4-15 days to consume a lethal dose and die. The total mean 
brodifacoum paste consumption was 320g over 28 nights. Five out of eight possum eating the 
brodifacoum paste took 15-25 nights to die. The remaining three took longer than 28 nights to 
die. 
Table 5: Mean consumption of various toxic cereal baits by captive possums over a four week period. All 
possums had previously survived a sub-lethal dose of 1080 (0.8 mg.kg-1 body weight). Means are presented ± 
SE. 
Group Toxin Base 
Material 
1 1080 RS5 
2 Cholecalciferol Commercial 
3 Brodifacoum RS5 
4 1080 Apple 
5 Cholecalciferol Apple 
6 Brodifacoum Apple 
I Excluding the nights that followed each possum's death 
2 R. Henderson unpublished data 
) Eason el at. 1994 
4 Henderson el al. 1994 
LDso 
mg.kg'! 
1.32 
153 
0.342 
1.52 
LD9s No. of Bait eaten per night! Mean 
mg.kg'! possums Total 
Night 1 Night 2-28 
3.32 10 0.63 + 0.43 0.17 + 0.04 2.9 
-
24.14 11 0.92 + 0.78 0.31+0.11 18 
0.82 11 6.62 + 3.49 12.45 + 1.12 281 
5.82 10 10.48 + 4.7 3.64 + 0.56 43 
9 26.22 + 6.6 3.06 + 0.68 42 
9 28.25 + 8.7 12.30 + 1.86 320 
5 Three possums were euthanised at the end of the four week feeding trial for humane reasons. All had consumed a lethal dose and were showing signs 
of anticoagulant poisoning. This was confirmed by a postmortem. 
DISCUSSION 
This trial supported the results of the preliminary 1995/96 trial in showing that is possible to 
kill 1080 shy possums using a sub-acute or chronic toxin in a familiar cereal bait matrix. Both 
trials also suggest that there is little difference in the effectiveness of cholecalciferol and 
brodifacoum as a mean of overcoming 1080 bait shyness. 
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Days to 
death 
6-36 
18-23 
4-15 
15-255 
The effect of changing the bait matrix appears to be twofold. Firstly, this trial showed that it 
is possible to kill some 1080 shy possum using 1080 in a new bait matrix. This result 
supports Morgan's (1996) research, in which the greatest success in overcoming 1080 
shyness was obtained by switching both the bait matrix and lure. 
The second effect is that it reduces the initial level of shyness. All possums ate more paste, on 
average, on the first night than those feeding on cereal. This enhanced the effectiveness of the 
cholecalciferol and brodifacoum toxins, with both achieving a 100% kill. In contrast, several 
possums survived the cholecalciferol and brodifacoum cereal treatments, apparently by 
avoiding the bait matrix throughout the trial. It seems that the surviving possums were 
'averse' to the cereal bait package and this could not be overcome by changing the toxin, 
whereas in the paste treatment all the possums ate some paste on the first night and eventually 
consumed a lethal dose. 
Previous research has attempted to identify whether possums develop an aversion to the toxin 
or the bait matrix. The results of this trial suggest that an aversion to the bait matrix can be 
partially overcome by switching to a sub-acute or chronic toxin. Because of the slow acting 
nature of these toxins possums are able to consume sub-lethal doses without the onset of 
poisoning symptoms. With regards to toxin detection this trial and Morgan's (1996) trial 
both suggest that some possums are unable to detect the 1080 toxin once the bait matrix has 
been changed. However, re-exposing 1080 shy possums to an acute toxin in a new matrix 
does not appear to be as effective as using a sub-acute or chronic toxin in the same or in a 
new bait matrix. What this suggests is that 1080 shy possums appear to develop a cautious 
feeding strategy (Hickling 1994), particularly in response to a familiar bait matrix. It would 
be interesting to trial an unfamiliar acute toxin (gliftor) in a new bait matrix to test this 
hypothesis. 
In conclusion, the majority of the results of this trial confirmed predictions based on previous 
research work. However, I was surprised to observe the high mean total consumption of 1080 
paste. One would expect any possums eating a sub-lethal dose of 1080 to develop an aversion 
to the new bait matrix. This was not the case, with most possums continuing to consume 
small sub-lethal amounts of bait. Nevertheless, the only possums consuming a lethal dose did 
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so on the first night. 1080 has a much lower toxicity in the paste matrix than in cereal (R. 
Henderson, unpubl. data). Therefore, it may be that the small amounts of paste being eaten 
were not producing severe poisoning symptoms as the sub-lethal 1080 cereal dose. Another 
consideration is that the paste desiccates by between 8-15% per night. While controls were 
placed out to estimate the rate of desiccation perhaps some of the paste consumption could 
have been caused by variations in this rate. This did not seem to a problem with the other 
paste treatments but could be worth considering in further bait consumption trials involving a 
paste matrix. 
RECOMMENDATIONS 
Switching to a sub-acute/chronic toxin is an effective way of overcoming 1080 shyness 
however, the best results are achieved when all components of the bait packages are 
unfamiliar. I believe that further research should: i) investigate the practicability of the new 
paste bait in the field and ii) investigate the effectiveness of other bait matrixes. While the 
results of this trial confirm that sub-acute or chronic toxins will be the most effective, I 
recommend trialing an unfamiliar acute toxin in the apple-paste bait to confirm this 
hypothesis. Brodifacoum and cholecalciferol were equally effective at killing 1080 shy 
possums. Given that cholecalciferol has major cost and environmental advantage it seems 
likely that this toxin is the current best alternative toxin to 1080 for maintenance possum 
control. 
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APPENDIX 1 
Appendix 1: Amounts of toxic cereal baits eaten by possums over 4 weeks after a sub-
lethal dose of 1080 (0.8mg.kg-l body weight). 
Toxin Possum Weight Night 1 Total Night until 
(kg) consumption (g) deathl 
1080 21 3.86 0 3.6 Survived 
40 3.19 0 2.8 Survived 
24 3 0.1 0.7 Survived 
38 2.96 1.6 1.6 Survived 
8 2.72 0 1.3 Survived 
5 2.56 0.4 4.6 Survived 
27 2.53 0 1.0 Survived 
25 2.3 0.1 7.1 Survived 
23 2.3 0 1.2 Survived 
31 2.06 4.7 5.8 Survived 
MEAN 2.97 
Cholecalciferol 14 3.37 0 0.4 Survived 
11 3.11 0 0.8 Survived 
41 2.81 0 13.1 15 
44 2.52 0.6 2.2 Survived 
63 2.75 1.8 54 6 
9C 2.05 0 8 36 
8D 2.43 4.7 50 4 
12D 1.92 0 33 5 
12F 2.55 0 2 Survived 
lIB 2.81 1.3 16 7 
lIB 2.81 1.3 16 7 
MEAN 17.77 
Brodifacoum 3 3.39 9.5 196 20 
13 3.32 0.2 299 Survivo~ 
48 3.13 13.7 578 18 
4 2.91 0 210 23 
45 2.77 0.4 409 Survivo~ 
18 2.69 0.7 759 Survivo~ 
30 2.52 9.4 170 18 
20 2.4 0 63 Survivor 
2.34 0.8 44 Survivor 
28 2.37 38.1 304 18 
42 1.96 0 60 Survivor 
MEAN 281.09 
1 Survival was monitored for 30 days post treatment 
2 These possums were euthanised at the end of the 4 week feeding trial for humane reasons. All had consumed a lethal dose 
and were showing signs of anticoagulant poisoning. This was confirmed by an autopsy 
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APPENDIX 2 
Appendix 2: Amounts of toxic paste eaten by possums over 4 weeks after a sub-
lethal dose of 1080 (0.8mg.kg-l body weight). 
Toxin Possum Weight Night 1 Total Night until 
(kg) consumption (g) death l 
1080 paste 29 3.0 14.4 14.4 1 
45 2.7 0.6 12.89 Survivor 
10 2.38 0.2 105.1 Survivor 
15 2.39 6.6 55.1 Survivor 
23 2.95 0.9 10.1 Survivor 
6 2.47 3.3 59.8 Survivor 
27 2.18 37.6 37.6 1 
11 1.87 37.4 37.4 
31 2.1 3.9 56.4 Survivor 
34 2.38 45.3 45.3 1 
MEAN 43.41 
Cholecalciferol 48 2.57 37.9 38.3 5 
37 2.71 1.3 31.98 5 
21 2.39 0.6 26.4 5 
47 2.37 37.7 41.9 5 
36 2.28 43.4 56.6 4 
5 2.4 0 32 5 
32 2.14 49.5 51.5 5 
26 2.05 36.7 47.6 5 
4 2.26 28.8 54.5 15 
MEAN 42.30 
Brodifacoum 3.23 7 131.1 Survivor 
18 2.23 66.7 653.1 15 
16 2.37 0 361.8 Survivor 
12 2.3 38 300.5 18 
39 2.11 6.8 322.8 22 
19 1.94 32.6 208 15 
33 2.01 0 438.6 25 
20 1.52 63.1 237.2 Survivor 
35 1.38 40 223.9 21 
MEAN 319.66 
I Survival was monitored for 30 days post treatment 
2 These possums were euthanised at the end of the 4 week feeding trial for humane reasons. All had consumed a lethal 
dose and were showing signs of anticoagulant poisoning. This was confirmed by an autopsy 
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